Key statistics
On Friday, Lineage Cell Therapeutics Inc (BT3:STU) closed at 0.825, 17.02% above the 52 week low of 0.705 set on Aug 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.79 |
---|---|
High | 0.825 |
Low | 0.78 |
Bid | 0.81 |
Offer | 0.855 |
Previous close | 0.775 |
Average volume | 0.00 |
---|---|
Shares outstanding | 188.84m |
Free float | 188.00m |
P/E (TTM) | -- |
Market cap | 177.51m USD |
EPS (TTM) | -0.1342 USD |
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
- Lineage Presents Preclinical Data on Its Auditory Neuronal Cell Transplant Program, ReSonance™, at the 59th Annual Inner Ear Biology Workshop
- Lineage Cell Therapeutics to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
- Lineage Cell Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
- Lineage Cell Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024
- Lineage Cell Therapeutics Added to Membership of 2024 Russell 3000® Index
More ▼